Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease

Cancer Investigation
E SalloumD L Cooper

Abstract

We reviewed all reported cases of Burkitt's lymphoma and/or Burkitt's leukemia (BLL) occurring following therapy for Hodgkin's disease. In addition to the case described in this report, a total of 19 patients have been previously reported. The male/female ratio was 3.75. Treatment for Hodgkin's disease included chemotherapy combined with radiation therapy in 15 patients, chemotherapy in 3 patients, and radiation therapy alone in 1 patient. Median interval between Hodgkin's disease and the diagnosis of BLL was 97 months. Patient characteristics are similar to those with de novo BLL. Bone marrow, abdomen, central nervous system, as well as extranodal organs were commonly involved. Typical cytogenetic translocations seen in patients with primary BLL were found in 6 patients, but 5 of these patients had additional cytogenetic abnormalities. Only 2 patients achieved complete remission after chemotherapy. The mechanism for the development of BLL after treatment for Hodgkin's disease is unknown. Although the majority of cases have been seen in patients treated with combined-modality therapy, the role of previous therapy in causing this complication cannot be assessed in this study.

References

Oct 1, 1979·Cancer·C BoucheixG Bilski-Pasquier
Mar 1, 1979·The New England Journal of Medicine·J G KrikorianH S Kaplan
Dec 1, 1979·Cancer·G AuclercJ Bernard
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L McMasterJ D Hainsworth
Jan 4, 1990·The New England Journal of Medicine·J M KaldorD Assouline
Dec 1, 1989·The British Journal of Radiology·A C RobinsonD Carney
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F E van LeeuwenA A Hart
Feb 1, 1988·British Journal of Haematology·P SonneveldJ Abels
Jan 14, 1988·The New England Journal of Medicine·M A TuckerS A Rosenberg
Mar 1, 1983·Archives of Internal Medicine·J O ArmitageR D Gingrich
Jul 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W J TesterV T DeVita
Jan 1, 1980·Acta Haematologica·J M AndrieuG Flandrin
Mar 1, 1981·American Journal of Clinical Pathology·C F ArkinJ T Sparks
Feb 1, 1982·American Journal of Hematology·V H NassarJ M Bennett
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W H WilsonB D Cheson
Apr 1, 1994·British Journal of Haematology·M N NarayananJ H Scarffe
Feb 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J F AbrahamsenH Høst
Sep 1, 1963·Annals of Internal Medicine·M J LACHER, L N SUSSMAN

❮ Previous
Next ❯

Citations

Sep 30, 2003·Medical and Pediatric Oncology·Takashi MiyagiMasato Masuda
Mar 11, 2017·Journal of Medical Case Reports·Alexandra E QuimbyStephanie Johnson-Obaseki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
C F HessM Bamberg
© 2021 Meta ULC. All rights reserved